Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Hamilton Partner on Target Prep Instrument

NEW YORK (GenomeWeb News) – Hamilton Robotics today said that it has partnered with Affymetrix on the development of a target preparation system for Affy's CytoScan cytogenetics assay.

It said that the CytoScan Automated Target Preparation Solution, which Affymetrix intends to launch soon, has been built on Hamilton's Microlab Nimbus 96 workstation.

Tanya Petrossian, global strategic product manager for Affymetrix, said in a statement that the new system will increase sample throughput at least two-fold for labs that offer the firm's CytoScan.

Last week at the JP Morgan Healthcare Conference Affymetrix President and CEO Frank Witney said that the firm plans to file for US Food and Drug Administration clearance for its CytoScan platform in the first quarter of this year for post-natal applications.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.